Concussion Imaging Market Size to Surpass US$ 10.51 Billion by 2031 – Growth Plus Reports

Newark, New Castle, USA, June 20, 2023 (GLOBE NEWSWIRE) — According to a new analysis by Growth Plus Reports, the global concussion imaging market is estimated to be worth US$ 10.51 billion by 2031, with a revenue CAGR of 3.95%. The study examines the key strategies, factors and prospects, competitive landscape, evolving industry patterns, market size, financial information and forecasts, and potential business opportunities.

Key Takeaways:

• The increasing prevalence of concussion caused by road accidents and sports injuries will drive market growth.
• Increasing need for early diagnosis will support market revenue growth.
• North America will dominate the global market with the largest revenue share.

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/concussion-imaging-market/8625

                                          Concussion Imaging Market Scope

Market Drivers
rising rates of concussion due to sports, road accidents, and military operations are the primary factor driving the revenue growth of the concussion imaging market. Furthermore, the enhancement of concussion diagnostic accuracy and precision with the development of modern imaging techniques including CT scan, MRI, and PET scan.is expected to contribute to market revenue growth. Besides this, an increase in concussion imaging adoption, as well as an increased awareness of concussions’ long-term effects and the importance of early detection and treatment will boost market revenue growth. 

Market Segmentation
Growth Plus Reports has analyzed the global concussion imaging market from four perspectives: Type, End User, and Region.

Type Segmentation: Based on the material, the concussion imaging market is segmented into computed tomography (CT) scans, magnetic resonance imaging (MRI) devices, X-rays, positron emission tomography (PET) scans, and others. The magnetic resonance imaging (MRI) devices segment dominates the market with the largest revenue share because of the increasing public awareness of the long-term effects of concussion and the need of early diagnosis and care.

End User Segmentation: Based on the end user, the concussion imaging market is segmented into hospitals & clinics, diagnostic centers, research institutes, and others. The hospitals & clinics segment dominates the market with the largest revenue share because of the availability of modern diagnostic and treatment technology, as well as specialized medical professionals such as neurologists and neurosurgeons.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/concussion-imaging-market/8625

Regional Growth Dynamics
Based on the region, the global concussion imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominates the global concussion imaging market with the largest revenue share. The rising prevalence of concussions caused by road accidents and sports injuries, increased government programs and awareness campaigns, increased market partnerships, mergers, and acquisitions, technology advances, and sophisticated healthcare infrastructure are the major factors responsible for North America’s significant revenue share in the global market. 

Competitive Landscape
The following companies are important players in the global concussion imaging market:

• Medtronic Plc
• Elekta AB
• Compumedics Limited
• Abbott Laboratories Inc.
• NovaSignal Corporation
• Integra Lifesciences
• Raumedic AG
• Nihon Kohden Corporation
• BrainScope Company Inc.
• InfraScan, Inc.
• BioDirection, Inc.
• NanoDiagnostics, Inc

There is moderate competition in the concussion imaging market. To introduce novel drugs and products, the major players in the market emphasize research and development. Major companies often engage in mergers and acquisitions to enhance their market share.

Recent developments:

• BrainBox Solutions Inc., a Richmond biotech that develops an artificial intelligence-enabled concussion test, obtained a broad patent from the US Patent and Trademark Office in March 2022 for a collection of eight biomarkers correlating to MRI scan findings.
• General Dynamics Information Technology (GDIT), a General Dynamics commercial unit, stated in December 2022 that the Defense Health Agency (DHA) had awarded them a $84 million contract to assist the Traumatic Brain Injury Center of Excellence (TBICoE). The contract has an eight-month base period and three option years.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL CONCUSSION IMAGING MARKET- ANALYSIS & FORECAST, BY TYPE
   1. Computed Tomography (CT) Scan
   2. Magnetic Resonance Imaging (MRI) Devices
   3. X-ray 
   4. Positron Emission Tomography (PET) Scans
   5. Others
6. GLOBAL CONCUSSION IMAGING MARKET- ANALYSIS & FORECAST, BY END USER
   1. Hospital & Clinics
   2. Diagnostic Centers 
   3. Research Institutes

CONCUSSION IMAGING MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8625

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Sympathomimetic Drugs Market by Type (Direct, Indirect, Mized), Indications (Cardiovascular Diseases, Asthma & COPD), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Cortisone Acetate Market by Indication (Rheumatic Diseases, Dermatologic Conditions), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Belladonna Alkaloids Market by Type (Atropine, Hyoscyamine), Application (Gastrointestinal Disorders, Respiratory Disorders, Overactive Bladder), Route of Administration (Oral, Topical), End User (Hospitals, Pharmaceutical Companies)-Global Outlook & Forecast 2023-2031

Calcium Homeostasis Drugs Market by Drug Class (Calcium Metabolism Modifiers, Parathyroid Hormone Analogs), Indication (Hypocalcemia, Hypercalcemia), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.